Translational Control of Immune Evasion in Cancer: Trends in Cancer

Por um escritor misterioso

Descrição

Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Tumor microenvironment-mediated immune evasion in
Translational Control of Immune Evasion in Cancer: Trends in Cancer
PD-L1-mediated immune evasion in triple-negative breast cancer is
Translational Control of Immune Evasion in Cancer: Trends in Cancer
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Translational control in cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
A membrane-associated MHC-I inhibitory axis for cancer immune
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Integrating innate and adaptive immunity in oncolytic virus
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion
Translational Control of Immune Evasion in Cancer: Trends in Cancer
IJMS, Free Full-Text
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Out of the cycle: Impact of cell cycle aberrations on cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Rho GTPase signaling in cancer progression and dissemination
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Gut Microbiota in Cancer Immune Response and Immunotherapy: Trends
Translational Control of Immune Evasion in Cancer: Trends in Cancer
New insights into the role of EMT in tumor immune escape - Terry
de por adulto (o preço varia de acordo com o tamanho do grupo)